Sharing the Steel: What The Every Company and ADM Are Quietly Teaching Us About Scale-Up

By | July 29, 2026
0 Comment
Abstract chart on aged paper showing rows of bioreactor vessel shapes of increasing height, some filled solid to represent existing manufacturing capacity and others left as outlines, with a rising curve tracing growth in demand.

The Every Company’s decision to manufacture its recombinant egg white protein OvoPro at ADM’s Clinton, Iowa facility, alongside existing capacity at Huvepharma’s Bulgarian subsidiary Biovet, illustrates a shift in how precision fermentation companies approach commercial scale-up. Rather than building proprietary plants, co-manufacturing allows capital to remain available for strain engineering and product development. The approach… Read More: Sharing the Steel: What The Every Company and ADM Are… »

A Tonne of Duck in One Run: What Parima and Vow Actually Proved

By | July 18, 2026
0 Comment
A large white duck stands in a misty wetland at sunrise near a stone etched with "VOW".

The headlines led with a 22,000-litre tank and a 99% cost drop. Here is a bioreactor engineer’s read on what Parima and Vow actually proved, why the media breakthrough matters more than the vessel, and the quiet shift that turned cultivated meat into a fermentation problem.

From Bioreactors to Brier Scores: Building Model90, a Football Prediction Engine

By | July 5, 2026
4 Comments

What happens when a bioreactor engineer points his state-estimation toolkit at football. Model90 is a statistical forecasting engine for the 2026 World Cup and the major leagues, built on Dixon-Coles Poisson, Elo, xG and a calibrated meta-model. An honest look at how it works and what its Brier score really means.

When the Steel Outlives the Startup: Inside UPSIDE’s $50M Bid for Believer Meats

By | June 19, 2026
0 Comment
Series of Stainless Steel Bioreactors Illustration

UPSIDE Foods has bid $50 million for Believer Meats’ North Carolina plant. The interesting question isn’t the price — it’s which parts of a dead cultivated-meat company are actually worth buying: the steel, the biology, or the process intelligence.

I Built a Single-Cell RNA-seq Pipeline That Writes Its Own Report

By | June 7, 2026
0 Comment
TIL-Scope

Single-cell RNA sequencing is one of those techniques that generates a huge amount of data and then demands a huge amount of effort to interpret it. You run the sequencer, get a matrix of 20,000 genes by several thousand cells, and then spend the next several days (or weeks) figuring out what’s in there. I… Read More: I Built a Single-Cell RNA-seq Pipeline That Writes Its Own… »

Cracker Blaster: a little block puzzle I built for my daughter

By | June 4, 2026
0 Comment

A small, cracker-themed block puzzle I cloned and polished for my four-year-old — built in plain vanilla JavaScript with synthesised audio, a Three.js bloom backdrop, and a deliberately forgiving combo system. Free to play, open source on GitHub.

From Lab Bench to Browser: A Hybrid Digital Twin for CHO Cell Culture

By | May 30, 2026
0 Comment
CHO Digital Twin

I rebuilt two published CHO cell-culture papers — a hybrid ODE + machine-learning growth model, and a genome-scale metabolic reduction pipeline — as an interactive digital twin that runs in the browser. Here’s how it works, what’s under the hood, and an honest take on what it’s good for. No hosted version yet; the code is on GitHub and a live instance is coming soon.

The Ovalbumin Patent Fight and What It Tells Us About Where Precision Fermentation Is Going

By | May 22, 2026
0 Comment
Ovalbumin Wars

The Every Company and Onego Bio are now fighting over recombinant ovalbumin in courts on two continents. The way this case resolves will shape how broadly IP rights can be enforced in precision fermentation, and what that means for the rest of us building this industry.